Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure
- Author
- LENZEN, Mattie J1 ; BOERSMA, Eric1 ; OP REIMER, Wilma J. M. Scholte1 ; BALK, Aggie H. M. M1 ; KOMAJDA, Michel2 ; SWEDBERG, Karl3 ; FOLLATH, Ferenc4 ; JIMENEZ-NAVARRO, Manuel5 ; SIMOONS, Maarten L1 ; CLELAND, John G. F6
[1] Department of Cardiology, Erasmus MC, Room Ba561, PO Box 2040, 3000 CA Rotterdam, Netherlands
[2] Department of Cardiology, Pitié-Salpêtrière Hospital, Paris, France
[3] Götebors University and Sahlgrenska University Hospital/Östra, Goteborg, Sweden
[4] Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
[5] Department of Cardiology, Hospital Clinico Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
[6] Department of Cardiology, Castle Hill Hospital, Kingston upon Hull, United Kingdom - Source
European heart journal. 2005, Vol 26, Num 24, pp 2706-2713, 8 p ; ref : 43 ref
- ISSN
- 0195-668X
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Oxford University Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Heart failure Randomized clinical trials Treatment Under-utilization
- Keyword (fr)
- Appareil circulatoire Cardiologie Enquête Essai clinique Homme Insuffisance cardiaque Médecine factuelle Phlébologie Randomisation Sevrage toxique Surveillance Traitement Euro Appareil circulatoire pathologie Cardiopathie
- Keyword (en)
- Circulatory system Cardiology Survey Clinical trial Human Heart failure Evidence-based medicine Phlebology Randomization Poison withdrawal Surveillance Treatment Cardiovascular disease Heart disease
- Keyword (es)
- Aparato circulatorio Cardiología Encuesta Ensayo clínico Hombre Insuficiencia cardíaca Medicina basada en pruebas Flebología Aleatorización Destete tóxico Vigilancia Tratamiento Aparato circulatorio patología Cardiopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17327209
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/eurheartj/ehi499 
https://dx.doi.org/10.1093/eurheartj/ehi499
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:9:\"\u0000*\u0000jtitle\";s:22:\"European heart journal\";s:9:\"\u0000*\u0000stitle\";s:12:\"Eur. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2713\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0195-668X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LENZEN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Mattie J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"BOERSMA, Eric\";i:1;s:30:\"OP REIMER, Wilma J. M. Scholte\";i:2;s:19:\"BALK, Aggie H. M. M\";i:3;s:15:\"KOMAJDA, Michel\";i:4;s:14:\"SWEDBERG, Karl\";i:5;s:15:\"FOLLATH, Ferenc\";i:6;s:23:\"JIMENEZ-NAVARRO, Manuel\";i:7;s:18:\"SIMOONS, Maarten L\";i:8;s:18:\"CLELAND, John G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:9:\"\u0000*\u0000jtitle\";s:22:\"European heart journal\";s:9:\"\u0000*\u0000stitle\";s:12:\"Eur. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2713\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0195-668X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LENZEN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Mattie J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"BOERSMA, Eric\";i:1;s:30:\"OP REIMER, Wilma J. M. Scholte\";i:2;s:19:\"BALK, Aggie H. M. M\";i:3;s:15:\"KOMAJDA, Michel\";i:4;s:14:\"SWEDBERG, Karl\";i:5;s:15:\"FOLLATH, Ferenc\";i:6;s:23:\"JIMENEZ-NAVARRO, Manuel\";i:7;s:18:\"SIMOONS, Maarten L\";i:8;s:18:\"CLELAND, John G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:9:\"\u0000*\u0000jtitle\";s:22:\"European heart journal\";s:9:\"\u0000*\u0000stitle\";s:12:\"Eur. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2713\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0195-668X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LENZEN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Mattie J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"BOERSMA, Eric\";i:1;s:30:\"OP REIMER, Wilma J. M. Scholte\";i:2;s:19:\"BALK, Aggie H. M. M\";i:3;s:15:\"KOMAJDA, Michel\";i:4;s:14:\"SWEDBERG, Karl\";i:5;s:15:\"FOLLATH, Ferenc\";i:6;s:23:\"JIMENEZ-NAVARRO, Manuel\";i:7;s:18:\"SIMOONS, Maarten L\";i:8;s:18:\"CLELAND, John G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:9:\"\u0000*\u0000jtitle\";s:22:\"European heart journal\";s:9:\"\u0000*\u0000stitle\";s:12:\"Eur. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2713\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0195-668X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LENZEN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Mattie J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"BOERSMA, Eric\";i:1;s:30:\"OP REIMER, Wilma J. M. Scholte\";i:2;s:19:\"BALK, Aggie H. M. M\";i:3;s:15:\"KOMAJDA, Michel\";i:4;s:14:\"SWEDBERG, Karl\";i:5;s:15:\"FOLLATH, Ferenc\";i:6;s:23:\"JIMENEZ-NAVARRO, Manuel\";i:7;s:18:\"SIMOONS, Maarten L\";i:8;s:18:\"CLELAND, John G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1093\/eurheartj\/ehi499\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:9:\"\u0000*\u0000jtitle\";s:22:\"European heart journal\";s:9:\"\u0000*\u0000stitle\";s:12:\"Eur. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"24\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2713\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0195-668X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LENZEN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Mattie J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"BOERSMA, Eric\";i:1;s:30:\"OP REIMER, Wilma J. M. Scholte\";i:2;s:19:\"BALK, Aggie H. M. M\";i:3;s:15:\"KOMAJDA, Michel\";i:4;s:14:\"SWEDBERG, Karl\";i:5;s:15:\"FOLLATH, Ferenc\";i:6;s:23:\"JIMENEZ-NAVARRO, Manuel\";i:7;s:18:\"SIMOONS, Maarten L\";i:8;s:18:\"CLELAND, John G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:221:\"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials : a report from the Euro Heart Survey on Heart Failure\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
